DR Horton, Inc. (NYSE:DHI) Actions raised by KBC Group NV


KBC Group NV increased its position in DR Horton, Inc. (NYSE: DHI – Get Rating) by 61.8% during the 1st quarter, according to the company in its latest communication to the Securities and Exchange Commission (SEC). The institutional investor owned 39,869 shares of the construction company after acquiring an additional 15,228 shares during the period. KBC Group NV’s holdings in DR Horton were worth $2,971,000 when it last filed with the SEC.

Other institutional investors also changed their positions in the company. IFM Investors Pty Ltd increased its position in DR Horton by 20.0% during the first quarter. IFM Investors Pty Ltd now owns 53,568 shares in the construction company valued at $3,991,000 after buying an additional 8,925 shares last quarter. Hazlett Burt & Watson Inc. acquired a new position in DR Horton during the first quarter worth approximately $30,000. Mader & Shannon Wealth Management Inc. increased its position in DR Horton by 3.3% during the first quarter. Mader & Shannon Wealth Management Inc. now owns 25,587 shares of the construction company valued at $1,906,000 after buying 821 additional shares last quarter. MCF Advisors LLC bought a new position in DR Horton during the first quarter worth approximately $32,000. Finally, Savant Capital LLC increased its position in DR Horton by 4.4% during the first quarter. Savant Capital LLC now owns 4,333 shares of the construction company valued at $323,000 after buying an additional 181 shares last quarter. 81.27% of the shares are held by hedge funds and other institutional investors.

Insider Activity at DR Horton

Separately, Vice Chairman Aron M. Odom sold 5,000 shares of the company in a trade on Friday, July 22. The shares were sold at an average price of $77.72, for a total transaction of $388,600.00. Following the completion of the transaction, the vice president now directly owns 3,024 shares of the company, valued at approximately $235,025.28. The transaction was disclosed in a filing with the SEC, which is available on the SEC’s website. In other news, Director Michael W. Hewatt sold 1,948 shares in a trade on Wednesday, May 25. The shares were sold at an average price of $67.97, for a total value of $132,405.56. Following completion of the transaction, the administrator now owns 5,067 shares of the company, valued at approximately $344,403.99. The sale was disclosed in a filing with the SEC, which is available at this link. Additionally, Vice Chairman Aron M. Odom sold 5,000 shares in a trade on Friday, July 22. The shares were sold at an average price of $77.72, for a total transaction of $388,600.00. Following the completion of the transaction, the vice president now owns 3,024 shares of the company, valued at approximately $235,025.28. The disclosure of this sale can be found here. Insiders sold a total of 10,948 shares of the company worth $829,286 in the past ninety days. 0.49% of the shares are currently held by insiders.

Wall Street analysts predict growth

A number of research analysts have recently commented on DHI’s actions. Goldman Sachs Group lowered its price target on DR Horton shares from $89.00 to $79.00 and set a “neutral” rating on the stock in a Thursday, June 23 research report. BTIG Research reduced its target price on DR Horton shares from $97.00 to $92.00 in a Friday, July 22 research report. UBS Group lowered its price target on DR Horton shares from $151.00 to $105.00 and set a “buy” rating for the company in a Thursday, June 16 research report. Royal Bank of Canada lowered its target price on DR Horton shares from $103.00 to $89.00 in a research report Wednesday, April 27. Finally, Wells Fargo & Company cut its price target on DR Horton stock from $86.00 to $73.00 and set an “overweight” rating for the company in a Friday, June 17 research report. Four research analysts gave the stock a hold rating, nine gave the stock a buy rating and one gave the stock a strong buy rating. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $95.14.

DR Horton Price Performance

Shares of DR Horton opened at $76.35 on Friday. The company has a fifty-day simple moving average of $71.76 and a 200-day simple moving average of $75.95. The company has a current ratio of 5.71, a quick ratio of 0.84 and a debt ratio of 0.32. DR Horton, Inc. has a 1-year minimum of $59.25 and a 1-year maximum of $110.45. The stock has a market capitalization of $26.53 billion, a price/earnings ratio of 4.90, a PEG ratio of 0.50 and a beta of 1.60.

DR Horton (NYSE:DHI – Get Rating) last released quarterly earnings data on Thursday, July 21. The construction company reported earnings per share of $4.67 for the quarter, beating analysts’ consensus estimate of $4.49 by $0.18. The company posted revenue of $8.79 billion in the quarter, versus $8.91 billion expected by analysts. DR Horton had a net margin of 17.42% and a return on equity of 33.33%. DR Horton’s revenue for the quarter increased 20.6% year over year. In the same period a year earlier, the company earned earnings per share of $3.06. On average, sell-side analysts expect DR Horton, Inc. to post earnings per share of 17.13 for the current year.

DR Horton Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, August 11. Investors of record on Thursday August 4 will receive a dividend of $0.225 per share. This represents an annualized dividend of $0.90 and a yield of 1.18%. The ex-dividend date is Wednesday, August 3. DR Horton’s payout ratio is currently 5.78%.

DR Horton Company Profile

(Get an assessment)

DR Horton, Inc operates as a residential construction company in the eastern, northern, southeast, south-central, southwest, and northwest regions of the United States. It deals with the acquisition and development of land; and building and selling residential homes in 31 states and 98 markets under the DR names

Featured articles

Institutional ownership by quarter for DR Horton (NYSE:DHI)



Get news and reviews for DR Horton Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for DR Horton and related companies with MarketBeat.com’s FREE daily newsletter.